Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Shire has agreed to pay $750 million to acquire Advanced BioHealing, a maker of a bioengineered skin substitute used in the treatment of diabetic foot ulcers. ABH had sales last year of $146 million, which Shire figures is about 5% of the potential market for slow-healing diabetic foot ulcer treatments. ABH was on the verge of making an initial public offering of stock when the deal was announced. Shire says ABH will be the core of a new business in regenerative medicine.
This article has been sent to the following recipient: